Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads

APMIS

Volumn 105, Issue 1, 1997, Pages 17-24

  Berge, V ^a,c   Johnson, E ^a   Hogasen K ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clusterin; EC; Terminal pathway

Indexed keywords

AGAROSE; CLUSTERIN; COMPLEMENT; REGULATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; UMBILICAL VEIN;

EID: 0030782508     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb00534.x     Document Type: Article

References (37)

1. Aronow, B. J., Lund, D. S., Brown, T. L., Harmony, J. A. K & Witte, D. P.: Apolipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. USA: 1990: 725-729, 1993.
2. Berge, V., Johnson, E. & Nazir, M.: Effect of gamma-interferon on the synthesis of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro. APMIS 102: 554-558, 1994.
3. Berge, V., Berge, K. E. & Johnson, E.: Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro. In press. APMIS.
4. Berge, V., Johnson, E. & Berge, K. E.: Interleukin-1α, interleukin 6 and tumor necrosis factor α increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro. APMIS 104: 213-219, 1996.
5. Blaschau, O., Burdzy, K. & Fritz, I. B.: Purification and characterization of a cell-aggregation factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 12: 7714-7720, 1983.
6. Buttyan, R., Olsson, C. A., Pintar, J., Chang, C., Bandyk, M., Ng, P. Y. & Sawezuk, I. S.: Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell Biol. 9: 3473-3481, 1988.
7. Choi, N.-H., Mazda, T. & Tomita, M.: A serum protein SP 40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol. Immunol. 26: 835-840, 1989.
8. Choi, N. H., Hara, K., Yoshida, H. & Tomita, M.: Sandwich ELISA for quantitative measurement of SP-40,40 in seminal plasma and serum. J. Immunol. Methods 131: 159-163, 1990.
9. De Silva, H. K. Harmony, J. A. K. Stuart, W. D., Gil, C. M. & Robbins, J.: Apolipoprotein J: Structure and tissue distribution. Biochemistry 29: 5380-5389, 1990.
10. Eli, S., Cheng, C. Y., Marshall, A. & Reidenberg, M. M.: Urinary clusterin in chronic nephrotoxicity in the rat. Proc. Soc. Exp. Biol. Med. 202: 487-490, 1993.
11. Grima, J., Zwain, I., Lockshin, R. A., Bardin, C. W. & Cheng, C. Y.: Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 126: 2989-2997, 1990.
12. Guc, D., Gulati, P., Lemercier, C., Lappin, D., Birnie, G. D. & Whaley, K.: Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol. Int. 13: 139-146, 1993.
13. Hardardóttir, I., Kunitake, S. T., Moser, A. H., Doerrier, T., Rapp, J. H., Griinfeld, G. & Feingold, K. R.: Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J. Clin. Invest. 94: 1304-1309, 1994.
14. Hogg, N. & Landis, R. C.: Adhesion molecules in cell interactions. Curr. Opin. Immunol. 5: 583-590, 1993.
15. Hynes, R. O.: Integrins: versatility, modulation and signaling in cell adhesion. Cell 69: 11-25, 1992.
16. Hogåsen, K., Mollnes, T. E., Tschopp, J. & Harboe, M.: Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins. J. Immunol. Methods 160: 107-115, 1993.
17. Hogåsen, K., Homann, C., Mollnes, T. E., Graudal, N., Hogåsen, A. K. M., Hasselqvist, P., Thomsen, A. C. & Garred, P.: Serum clusterin and vitronectin in alcoholic cirrhosis. Liver 16: 140-146, 1996.
18. Jaffe, E. A., Nachmam, R. L., Becker, C. G. & Minick, C. R.: Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J. Clin. Invest. 52: 2745-2752, 1973.
19. Jeune, D. E. & Tschopp, J.: Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc. Natl. Acad. Sci. USA 86: 7123-7127, 1989.
20. Johnson, E. & Hetland, G.: A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro. Scand. J. Clin. Lab. Invest. 45: 223-231, 1988.
21. Johnson, E. & Hetland, G.: Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro. Scand. J. Immunol. 33: 667-671, 1991.
22. Johnson, E., Berge, V. & Hogåsen, K.: Formation of the terminal complement complex on agarose beads: Further evidence that vitronectin (complement S-protein) inhibits C9 polymerization. Scand. J. Immunol. 39: 281-285, 1994.
23. Jordan-Starck, T. C., Lund, S. D., Witte, D. P., Aronow, B. J., Ley, C. A., Stuart, W. D., Swertfeger, D. K., Clayton, L. R., Sells, S. F., Paigen, B. & Harmony, J. A. K.: Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J. Lipid Res. 35: 194-210, 1994.
24. Kirzbaum, L., Sharpe, J. A., Murphy, B., d'Apice, A. J. F., Classon, B., Hudson, P. & Walker, I. A.: Molecular cloning and characterization of novel, human complement-associated protein, SP-40,40: A link between the complement and reproductive systems. EMBO J. 8: 711-718, 1989.
25. Mollnes, T. E., Lea, T., Harboe, M. & Tschopp, J.: Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand. J. Immunol. 93: 409-420, 1983.
26. Murphy, B. F., Saunders, J. R., O'Bryan, M. K. Kirszbaum, L., Walker, I. D. & d'Apice, A. J. F.: SP-40,40 is an inhibitor of C5b-6-initiated haemolysis. Int. Immunol. 1: 551-554, 1989.
27. Murphy, B. F., Kirszbaum, L., Walker, I. D. & d'Apice, A. J. F.: SP-40,40, a newly identified normal human serum protein found in the SCSb-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81: 1858-1864, 1988.
28. Roitt, I., Brostoff, J. & Male, D.: Immunology, 2.14, Churchill Livingstone, 1986.
29. Rosenberg, M. R. & Silkensten, J.: Clusterin: Physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 27: 633-645. 1995.
30. Roth, G. J.: Platelet and blood vessels: the adhesion event. Immunol. Today 13: 100-105, 1992.
31. Schlegel, P. N., Matthews, G. J., Cichon, Z., Aulitzky, K., Cheng, C. Y., Chen, C.-L. C., Saso, L., Goldstein, M., Janne, O. A. & Bardin, C. W.: Clusterin production in the obstructed rabbit kidney: Correlations with loss of renal function. J. Am. Soc. Nephrol. 3: 1163-1171, 1992.
32. Sims, P. J. & Wiedmer, T.: The response of human platelets to activated components of the complement system. Immunol. Today 12: 338-342, 1991.
33. Tschopp, J., Chonn, A., Hertig, S. & French, L., E.: Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8ß, and the b domain of C9. J. Immunol. 151: 2159-2165, 1993.
34. Tschopp, J., Jenne, D .E., Hertig, S., Preissner, K. T., Morgenstern, H., Sapino, A. P. & French, L: Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into α-granules. Blood 82: 118-125, 1993.
35. Witte, D. P., Aronow, B. J., Stauderman, M. L., Stuart, W. D., Clay, M A., Gruppo, R. A., Jenkins, S. H. & Harmony, J. A. K.: Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am. J. Pathol. 143: 763-773, 1993.
36. Zimmerman, G. A., Prescott, S. M. & McIntyre, T. M.: Endothelial cell interaction with granulocytes: tethering and signaling molecules. Immunology 13: 93-100, 1992.
37. Zwain, I. H., Grima, J. & Cheng, C. Y.: Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines. Mol. Cell. Neurosci. 5: 229-237, 1994.